P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES

• Kadère Konté,
• Aafke Gaartman,
• Rob van Zwieten,
• Martijn Veldthuis,
• Robin van Bruggen,
• Bart Biemond,
• Erfan Nur

Affiliations

Kadère Konté

1 Amsterdam University Medical Centers, Department of Clinical Hematology, Amsterdam, The Netherlands

Aafke Gaartman

1 Amsterdam University Medical Centers, Department of Clinical Hematology, Amsterdam, The Netherlands

Rob van Zwieten

2 Sanquin Research, Department of Blood Cell Research, Amsterdam, The Netherlands

Martijn Veldthuis

2 Sanquin Research, Department of Blood Cell Research, Amsterdam, The Netherlands

Robin van Bruggen

2 Sanquin Research, Department of Blood Cell Research, Amsterdam, The Netherlands

Bart Biemond

1 Amsterdam University Medical Centers, Department of Clinical Hematology, Amsterdam, The Netherlands

Erfan Nur

1 Amsterdam University Medical Centers, Department of Clinical Hematology, Amsterdam, The Netherlands